The estimated annual incidence of oral cavity and pharyngeal cancer is 39,000 in the United
States and 260,000 cases worldwide. Despite significant advances in surgery …

With the recent explosion in high-throughput genotyping technology, the amount and quality
of SNP data have increased exponentially, facilitating the discovery of multiple uncommon …

Abstract HNSCC (Head and Heck Squamous Cell Carcinoma) is a reasonably prevalent
cancer with a high mortality rate. In this study, we tried to examine the anti-metastasis and …

Head and neck squamous cell carcinoma (HNSCC) is one of the greatest public challenges
because of delayed diagnosis and poor prognosis. In this study, we established an …

Fibroblast growth factors (FGF) and their tyrosine kinase receptors (FGFR) support cell
proliferation, survival and migration during embryonic development, organogenesis and …

For the head and neck squamous cell carcinoma (HNSCC), surgery in combination with
radiation therapy is the current standard treatment. However, the complex anatomy and …

Simple Summary Head and neck cancer (HNC) is characterized by radio-and
chemoresistance contributing to treatment failure and poor prognosis. There is evidence that …

Background Since head and neck cancer is characterized by poor survival rates, there is a
demand for novel therapeutic targets and prognostic biomarkers. An upcoming therapeutic …

Background: Accumulated evidence shows that DNA repair gene X-ray repair cross
complementing group 1 (XRCC1) may determine individual susceptibility to head and neck …

Objective: The aim of this study was to investigate whether fibroblast growth factor receptor 4
(FGFR4) could serve as a potential therapeutic target, prognostic biomarker or biomarker …